
InSilicoMinds helps pharma and life sciences companies accelerate drug development with AI-driven modeling and simulation. It uses AI, in silico modeling and simulation, bioinformatics, computational chemistry, PBPK, and IVIVC to run virtual trials and optimize lead candidates. The firm leverages validated global solutions and a partnership with InSilicoTrials to expand its AI and simulation toolkit. Its services cover modeling and simulation, bioinformatics, computational biology/chemistry, clinical research, in silico trials, domain advisory, and staff augmentation. Targeting startups to large pharma, it aims to reduce costs, shorten development timelines, and improve patient outcomes.

InSilicoMinds helps pharma and life sciences companies accelerate drug development with AI-driven modeling and simulation. It uses AI, in silico modeling and simulation, bioinformatics, computational chemistry, PBPK, and IVIVC to run virtual trials and optimize lead candidates. The firm leverages validated global solutions and a partnership with InSilicoTrials to expand its AI and simulation toolkit. Its services cover modeling and simulation, bioinformatics, computational biology/chemistry, clinical research, in silico trials, domain advisory, and staff augmentation. Targeting startups to large pharma, it aims to reduce costs, shorten development timelines, and improve patient outcomes.